Management of myelodysplastic syndromes in adults: guidelines from the Belgian Haematological Society
- Author
- S Meers, D Breems, G Bries, M Delforge, C Graux, C Ravoet, D Selleslag and Lucien Noens (UGent)
- Organization
- Abstract
- Myelodysplastic syndromes (MDS) represent a heterogeneous group of haematological disorders characterized by ineffective haematopoiesis and an increased risk for leukemic transformation. In recent years several new therapeutics have emerged that have demonstrated to alter the natural course of the disease. This document summarizes the state of the art in diagnosis and treatment of this heterogeneous disease, as proposed by a group of expert haematologists in the field of MDS from the Belgian Haematological Society. Its main purpose is to guide clinicians in daily practice to treat patients with this disease, within the limitations of current reimbursement modalities in Belgium.
- Keywords
- guidelines, review, myelodysplastic syndromes, MD5, STEM-CELL TRANSPLANTATION, ACUTE MYELOID-LEUKEMIA, MDS STUDY-GROUP, ANTITHYMOCYTE GLOBULIN, G-CSF, IMMUNOSUPPRESSIVE THERAPY, INTENSIVE CHEMOTHERAPY, ELDERLY-PATIENTS, SCORING SYSTEM, SERUM FERRITIN
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 485.08 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-4214970
- MLA
- Meers, S., et al. “Management of Myelodysplastic Syndromes in Adults: Guidelines from the Belgian Haematological Society.” ACTA CLINICA BELGICA, vol. 68, no. 4, 2013, pp. 253–62, doi:10.2143/ACB.3424.
- APA
- Meers, S., Breems, D., Bries, G., Delforge, M., Graux, C., Ravoet, C., … Noens, L. (2013). Management of myelodysplastic syndromes in adults: guidelines from the Belgian Haematological Society. ACTA CLINICA BELGICA, 68(4), 253–262. https://doi.org/10.2143/ACB.3424
- Chicago author-date
- Meers, S, D Breems, G Bries, M Delforge, C Graux, C Ravoet, D Selleslag, and Lucien Noens. 2013. “Management of Myelodysplastic Syndromes in Adults: Guidelines from the Belgian Haematological Society.” ACTA CLINICA BELGICA 68 (4): 253–62. https://doi.org/10.2143/ACB.3424.
- Chicago author-date (all authors)
- Meers, S, D Breems, G Bries, M Delforge, C Graux, C Ravoet, D Selleslag, and Lucien Noens. 2013. “Management of Myelodysplastic Syndromes in Adults: Guidelines from the Belgian Haematological Society.” ACTA CLINICA BELGICA 68 (4): 253–262. doi:10.2143/ACB.3424.
- Vancouver
- 1.Meers S, Breems D, Bries G, Delforge M, Graux C, Ravoet C, et al. Management of myelodysplastic syndromes in adults: guidelines from the Belgian Haematological Society. ACTA CLINICA BELGICA. 2013;68(4):253–62.
- IEEE
- [1]S. Meers et al., “Management of myelodysplastic syndromes in adults: guidelines from the Belgian Haematological Society,” ACTA CLINICA BELGICA, vol. 68, no. 4, pp. 253–262, 2013.
@article{4214970,
abstract = {{Myelodysplastic syndromes (MDS) represent a heterogeneous group of haematological disorders characterized by ineffective haematopoiesis and an increased risk for leukemic transformation. In recent years several new therapeutics have emerged that have demonstrated to alter the natural course of the disease. This document summarizes the state of the art in diagnosis and treatment of this heterogeneous disease, as proposed by a group of expert haematologists in the field of MDS from the Belgian Haematological Society. Its main purpose is to guide clinicians in daily practice to treat patients with this disease, within the limitations of current reimbursement modalities in Belgium.}},
author = {{Meers, S and Breems, D and Bries, G and Delforge, M and Graux, C and Ravoet, C and Selleslag, D and Noens, Lucien}},
issn = {{0001-5512}},
journal = {{ACTA CLINICA BELGICA}},
keywords = {{guidelines,review,myelodysplastic syndromes,MD5,STEM-CELL TRANSPLANTATION,ACUTE MYELOID-LEUKEMIA,MDS STUDY-GROUP,ANTITHYMOCYTE GLOBULIN,G-CSF,IMMUNOSUPPRESSIVE THERAPY,INTENSIVE CHEMOTHERAPY,ELDERLY-PATIENTS,SCORING SYSTEM,SERUM FERRITIN}},
language = {{eng}},
number = {{4}},
pages = {{253--262}},
title = {{Management of myelodysplastic syndromes in adults: guidelines from the Belgian Haematological Society}},
url = {{http://doi.org/10.2143/ACB.3424}},
volume = {{68}},
year = {{2013}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: